The EU butts heads with Big Pharma to make medicines cheaper

By HEOR Staff Writer

February 2, 2023

The new EU proposal to revamp its pharmaceutical regulations. The main aim is to give people a better and more affordable access to medicines.

From what I can see, there are mixed feelings about the proposal. On one hand, consumer groups and civil society organizations are applauding the EU’s efforts to make medicines more accessible. On the other hand, the pharmaceutical industry is a bit skeptical.

So, what’s in the proposal? Well, the EU is looking to shorten the period in which pharmaceutical companies can sell their medicines without competition from 10 years to just 8 years. They’re also working towards closing the gap in access to medicines among different EU member states.

It’s interesting to see how this will all play out. What are your thoughts on the EU Pharmaceutical Regulations Proposal?

Reference url

Recent Posts

Zorginstituut Nederland’s Lecanemab Health Insurance Rejection: Implications for Alzheimer&...

By HEOR Staff Writer

February 18, 2026

Dutch Health Insurance Rejects Lecanemab Coverage Zorginstituut Nederland's advisory letter dated 13 February 2026 recommends against including lecanemab (Leqembi®) in the Dutch basic health insurance package, marking a key lecanema...
European Commission Approves Enhanced Wegovy Obesity Treatment Dose

By João L. Carapinha

European Commission Backs Wegovy Obesity Treatment with 7.2 mg Dose The European Commission has approved a higher 7.2 mg maintenance dose of
Revised MenACWY Vaccination Strategy for Adolescents in Germany

By HEOR Staff Writer

G-BA Approves MenACWY Vaccination Strategy Shift for Adolescents Germany's Federal Joint Committee (Gemeinsamer Bundesausschuss, G-BA) has approved key amendments to the Protective Vaccination Directive on December 18...